Ranbaxy was expected to launch its low-cost version in May, when the Nexium patent expired. Photo: Pradeep Gaur/Mint The Indian drug maker may... ...http://www.livemint.com/Companies/LaBtqMs81oU1AhzLywYb5O/Ranbaxy-may-lose-exclusivity-on-Nexium-generic.html
Announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer's disease AstraZeneca and Eli Lilly and Company (Lilly) have... ...http://pharma.financialexpress.com/latest-updates/4403-astrazeneca-and-lilly-in-agreement
ation Technology to speed up the processes, as its model to fight the challenges faced by the large multinational pharmaceutical companies in the... ...http://www.business-standard.com/article/companies/we-want-to-be-like-oxygen-to-astrazeneca-and-then-we-can-focus-on-innovation-david-smoley-114091700851_1.html
Singapore: As part of the campaign, Mr Van Der Beek stars in an informative and comedic video, called "Just the Flu Facts," in which he uses his... ...http://www.biospectrumasia.com/biospectrum/news/219011/its-start-studded-collaboration-astrazeneca?WT.rss_f=Home&WT.rss_a=Its+a+start-studded+collaboration+for+AstraZeneca++
While this is company's first such centre globally, it plans to establish two more technology centres in San Francisco (USA) and in Eastern Europe... ...http://www.business-standard.com/content/b2b-pharma/astrazeneca-sets-up-global-tech-centre-in-chennai-to-cut-it-cost-114091700414_1.html
IP Astra is an intellectual property...